Nektar to Announce Financial Results for the Second Quarter on Thursday, August 7, 2025, After Close of U.S.-Based Financial Markets

Rhea-AI Summary

Nektar Therapeutics (NASDAQ:NKTR) has scheduled its second quarter 2025 financial results announcement for Thursday, August 7, 2025, after U.S. market close. The company will host a conference call at 5:00 p.m. ET/2:00 p.m. PT, led by President and CEO Howard Robin.

Investors can access the audio-only webcast through the company's investor relations website at ir.nektar.com. The webcast replay will remain available until September 7, 2025. Participants wishing to join via phone must pre-register through the Nektar Earnings Call Registration link to receive dial-in information.

News Market Reaction – NKTR

+5.90%

10 alerts

+5.90% News Effect

+$21M Valuation Impact

$383M Market Cap

0.5x Rel. Volume

On the day this news was published, NKTR gained 5.90%, reflecting a notable positive market reaction. Our momentum scanner triggered 10 alerts that day, indicating notable trading interest and price volatility. This price movement added approximately $21M to the company's valuation, bringing the market cap to $383M at that time.

Data tracked by StockTitan Argus on the day of publication.

SAN FRANCISCO, July 31, 2025 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) will announce its financial results for the second quarter on Thursday, August 7, 2025, after the close of U.S.-based financial markets. Howard Robin, President and Chief Executive Officer, will host a conference call to review the results beginning at 5:00 p.m. Eastern Time/2:00 p.m. Pacific Time.

This press release and live audio-only webcast of the conference call can be accessed through a link that is posted on the Home Page and Investors section of the Nektar website: https://ir.nektar.com/. The web broadcast of the conference call will be available for replay through September 7, 2025.

To access the conference call by phone, please pre-register at Nektar Earnings Call Registration. All registrants will receive dial-in information and a PIN allowing them to access the live call. 

About Nektar Therapeutics

Nektar Therapeutics is a clinical-stage biotechnology company focused on developing treatments that address the underlying immunological dysfunction in autoimmune and chronic inflammatory diseases. Nektar's lead product candidate, rezpegaldesleukin (REZPEG, or NKTR-358), is a novel, first-in-class regulatory T cell stimulator being evaluated in two Phase 2b clinical trials, one in atopic dermatitis and one in alopecia areata. Nektar's pipeline also includes a preclinical bivalent tumor necrosis factor receptor type II (TNFR2) antibody and bispecific programs, NKTR-0165 and NKTR-0166, and a modified hematopoietic colony stimulating factor (CSF) protein, NKTR-422. Nektar, together with various partners, is also evaluating NKTR-255, an investigational IL-15 receptor agonist designed to boost the immune system's natural ability to fight cancer, in several ongoing clinical trials.

Nektar is headquartered in San Francisco, California. For further information, visit www.nektar.com and follow us on LinkedIn.

Contacts:

For Investors:

Corey Davis, Ph.D.
LifeSci Advisors, LLC
cdavis@lifesciadvisors.com  
212-915-2577

Ahu Demir, Ph.D.
LifeSci Advisors, LLC
ademir@lifesciadvisors.com
212-915-3820

For Media:

Madelin Hawtin
LifeSci Communications
603-714-2638
mhawtin@lifescicomms.com

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/nektar-to-announce-financial-results-for-the-second-quarter-on-thursday-august-7-2025-after-close-of-us-based-financial-markets-302518988.html

SOURCE Nektar Therapeutics

FAQ

When will Nektar (NKTR) release Q2 2025 earnings?

Nektar will release its Q2 2025 financial results on Thursday, August 7, 2025, after the U.S. financial markets close.

How can I listen to Nektar's Q2 2025 earnings call?

You can access the call through an audio-only webcast on ir.nektar.com or by phone after pre-registering through the Nektar Earnings Call Registration link.

What time is Nektar's Q2 2025 earnings call?

The earnings call will begin at 5:00 p.m. Eastern Time/2:00 p.m. Pacific Time on August 7, 2025.

How long will Nektar's Q2 2025 earnings call replay be available?

The web broadcast replay will be available through September 7, 2025.

Who will host Nektar's Q2 2025 earnings call?

Howard Robin, Nektar's President and Chief Executive Officer, will host the conference call.